Evidence that deprenyl, a type B monoamine oxidase inhibitor, is an indirectly acting sympathomimetic amine
- 1 January 1978
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 27 (11) , 1591-1595
- https://doi.org/10.1016/0006-2952(78)90490-2
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- The effects of behaviorally relevant doses of chlorpromazine and molindone on cardiac adenylate cyclase and on myocardial contractilityBiochemical Pharmacology, 1977
- COMPARISON OF ABILITIES OF CHLORPROMAZINE AND MOLINDONE TO INTERACT ADVERSELY WITH GUANETHIDINE1976
- The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formationEuropean Journal of Pharmacology, 1975
- A comparison of the pharmacological and biochemical properties of substrate‐selective monoamine oxidase inhibitorsBritish Journal of Pharmacology, 1972
- A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine, and 5-hydroxytryptamine from discrete brain areasAnalytical Biochemistry, 1971
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968
- STUDY OF FACTORS AFFECTING ALUMINUM OXIDE-TRIHYDROXYINDOLE PROCEDURE FOR ANALYSIS OF CATECHOLAMINES1962